Literature DB >> 16603836

Pemphigus vulgaris in Iran: epidemiology and clinical profile.

Ali Asilian1, Alireza Yoosefi, Gita Faghini.   

Abstract

BACKGROUND: Although the clinical profile of pemphigus vulgaris is generally well characterized, the epidemiologic differences are important but not widely evaluated. This study was conducted to evaluate the incidence and clinical profile of pemphigus patients in a large central province of Iran.
METHODS: Demographic variables, clinical manifestations, and side effects of treatment in 188 patients in a 10-year period were studied.
RESULTS: The annual incidence rate of pemphigus vulgaris was 5/100,000, with a 1.6:1 ratio of incidence in women compared with men. The mean age of onset was 41.1+/-13.7 years. In 74% of patients, the initial presentation of the disease was mucosal involvement, and in the remaining 26% the disease initially presented on the skin.
CONCLUSIONS: Iranian patients have a relatively young age of onset of pemphigus and a higher incidence among women than men, which may reflect geographic, cultural, dietetic, or racial differences in the clinical and biologic behavior of the disease.

Entities:  

Mesh:

Year:  2006        PMID: 16603836     DOI: 10.1111/j.1540-9740.2006.03756.x

Source DB:  PubMed          Journal:  Skinmed        ISSN: 1540-9740


  11 in total

Review 1.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

2.  Relieving Pain in Oral Lesions of Pemphigus Vulgaris Using the Non-ablative, Non-thermal, CO2 Laser Therapy (NTCLT): Preliminary Results of a Novel Approach.

Authors:  Nasrin Zand; Parvin Mansouri; Mohsen Fateh; Leila Ataie-Fashtami; Samad Rezaee Khiabanloo; Farid Safar; Reza Chalangari; Katalin Martits; Afshan Shirkavand
Journal:  J Lasers Med Sci       Date:  2017-01-08

3.  The Evaluation of Serum Lipids Profile in Patients with Pemphigus Vulgaris: A Case-Control Study.

Authors:  Fahimeh Rezazadeh; Maryam Moshaverinia; Farhad Handjani; Fatemeh Khoshkholgh; Nasrin Saki; Alireza Heiran
Journal:  Malays J Med Sci       Date:  2020-04-30

4.  Successful treatment of pemphigus vulgaris with the extensive mucocutaneous lesions in an elderly patient.

Authors:  Mohsen Masjedi; Ali Asilian; Zabihollah Shahmoradi; Parvin Rajabi Dehnavi; Bahareh Abtahi Naeini
Journal:  Iran Red Crescent Med J       Date:  2014-06-05       Impact factor: 0.611

5.  Pemphigus vulgaris and amyotrophic lateral sclerosis.

Authors:  Fatemeh Mokhtari; Marzieh Matin; Fatemeh Rajati
Journal:  J Res Med Sci       Date:  2016-10-18       Impact factor: 1.852

Review 6.  A review on botanicals with wound healing activity for pemphigus vulgaris: perspective of traditional Persian medicine and conventional medicine.

Authors:  Fatemeh Atarzadeh; Amir Mohammad Jaladat; Babak Daneshfard; Ladan Dastgheib; Mohammad Kamalinejad; Gholamreza Amin
Journal:  Avicenna J Phytomed       Date:  2017 Nov-Dec

7.  Evaluation of Sex Hormone Levels in Patients with Pemphigus Vulgaris in Comparison to the Healthy Population.

Authors:  Fatemeh Lavaee; Fahimeh Rezazadeh; Nasrin Saki; Zahra Tavazo; Saman Baghaei
Journal:  Biomed Res Int       Date:  2021-09-28       Impact factor: 3.411

8.  A clinical and demographic analysis of oral pemphigus vulgaris: A retrospective cross-sectional study from 2001 to 2021.

Authors:  Muhanad L Alshami; Fawaz Aswad; Bashar Abdullah
Journal:  Health Sci Rep       Date:  2022-09-13

9.  The impacts of a health belief model-based educational program on adopting self-care behaviors in pemphigus vulgaris patients.

Authors:  Roya Sadeghi; Azar Tol; Azita Moradi; Masoud Baikpour; Mostafa Hossaini
Journal:  J Educ Health Promot       Date:  2015-12-30

10.  A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up

Authors:  Zekayi Kutlubay; Ayşegül Sevim Keçici; Uğur Çelik; Mehmet Cem Mat
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.